Golden has been acquired by ComplyAdvantage.Read about it here ⟶

Kyprolis

carfilzomib

Overview Structured Data Issues Contributors Activity

All edits

Edits on 7 Apr, 2022

"Approved suggestion #1383661 from source: https://www.kyprolis.com"

Vitalii Mazuryk

approved a suggestion from Golden's AI on 7 Apr, 2022

Edits made to:

Infobox (+1 properties)

Infobox

Facebook

https://www.facebook.com/kyprolis

Vitalii Mazuryk

edited on 7 Apr, 2022

Edits made to:

Description (+11 characters)

Article (+393 characters)

Kyprolis

carfilzomib

Article

KYPROLIS® (carfilzomib) is a prescription medication used to treat adult patients with relapsed or refractory multiple myeloma who have received one to three previous treatments for multiple myeloma. KYPROLIS is approved for use in combination with daratumumab plus dexamethasone, dexamethasone or with lenalidomide plus dexamethasone, which are other medicines used to treat multiple myeloma.

"Edit from table cell"

Vitalii Mazuryk

edited on 7 Apr, 2022

Edits made to:

Infobox (+2 properties)

Infobox

Industry

Product parent company